[Pharmacotherapy of a 67-year old female with borderline personality disorder].

Pharmacotherapy in older adults with personality disorders is very complicated. On the one hand, this is caused by interference of the personality disorder in the therapeutic relationship. On the other hand, age specific factors, such as polypharmacy and changing pharmacokinetics and -dynamics play an important complicating role.

[Pharmacotherapy in older adults with personality disorders: a new area of attention].

Background: Pharmacotherapy in older adults with personality disorders (PD) is a new and important area of attention. Nowadays, symptom based pharmacotherapy in older adults with PD is based on multidisciplinary guidelines, which are constructed on research performed in patients up to 50 years of age. There is no specific guideline for older adults with PD.

A Life Span Perspective on Borderline Personality Disorder.

Purpose Of Review: To provide an update of a life span perspective on borderline personality disorder (BPD). We address the life span course of BPD, and discuss possible implications for assessment, treatment, and research.

Recent Findings: BPD first manifests itself in adolescence and can be distinguished reliably from normal adolescent development.